Failed cancer vaccines might live again with new immune drugs

MADRID, Sept 28 (Reuters) - Using vaccines to fight cancer is a field littered with failures but experts believe it is possible the approach could get a new lease of life if such shots are combined with a new class of drugs called checkpoint inhibitors.